Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 3 Sep 2022 - 9 Sep 2022
STUDY TYPE:Pharmacology/Drug Development
DATE PUBLISHED: 2022 Sep 06
JOURNAL:J Eur Acad Dermatol Venereol
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/36066323?dopt=Abstract
Ruxolitinib cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) 1/JAK2 inhibitor.